...
首页> 外文期刊>Toxicology and Applied Pharmacology >Long-enduring primary hepatocyte-based co-cultures improve prediction of hepatotoxicity
【24h】

Long-enduring primary hepatocyte-based co-cultures improve prediction of hepatotoxicity

机译:基于肝细胞的共培养物的长期寿命改善预测肝毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract The failure of drug candidates during clinical trials and post-marketing withdrawal due to Drug Induced Liver Injury (DILI), results in significant late-stage attrition in the pharmaceutical industry. Animal studies have proven insufficient to definitively predict DILI in the clinic, therefore a variety of in vitro models are being tested in an effort to improve prediction of human hepatotoxicity. The model system described here consists of cryopreserved primary rat, dog or human hepatocytes co-cultured together with a fibroblast cell line, which aids in the hepatocytes' maintenance of more in vivo -like characteristics compared to traditional hepatic mono-cultures, including long term viability and retention of activity of cytochrome P450 isozymes. Cell viability was assessed by measurement of ATP following treatment with 29 compounds having known hepatotoxic liabilities. Hμrelrat?, Hμreldog?, and Hμrelhuman? hepatic co-cultures were treated for 24h, or under repeat-dosing for 7 or 13days, and compared to rat and human hepatic mono-cultures following single-dose exposure for 24h. The results allowed for a comparison of cytotoxicity, species-specific responses and the effect of repeat compound exposure on the prediction of hepatotoxic potential in each model. Results show that the co-culture model had greater sensitivity compared to that of the hepatic mono-cultures. In addition, “time-based ratios” were determined by dividing the compounds' 24-hour TC 50 /C max values by TC 50 /C max values measured after dosing for either 7 or 13days. The results suggest that this approach may serve as a useful adjunct to traditional measurements of hepatotoxicity, improving the predictive value of early screening studies. Highlights ? An in vitro hepatocyte model with 14day survival is characterized. ? The model uses rat, human and dog hepatocyte/fibroblast co-cultures. ? Sensitivity and selectivity of the model are compared to 24h hepatic monocultures. ? Results show increased sensitivity for hepatotoxicants using the co-culture model.
机译:摘要临床试验期间药物候选者的失败和药物诱导肝损伤(DILI)导致营销后戒断,导致制药行业的显着晚期磨损。动物研究证明不足以明确地预测诊所的DiLi,因此正在测试各种体外模型,以提高人肝毒性的预测。这里描述的模型系统由冷冻保存的原代大鼠,狗或人肝细胞与成纤维细胞系一起培养,其有助于与传统的肝单培养物相比,包括长期的体内特征更加肝细胞的维持活性和保留细胞色素P450同工酶的活性。通过用已知的肝毒性负债的29种化合物测量ATP评估细胞活力。 hμrelrat?,hμreldog?,和hμrelhuman?将肝共培养物处理24小时,或在重复给药7或13天,并与单剂量暴露后的大鼠和人肝单培养物相比24小时。结果允许比较细胞毒性,物种特异性反应以及重复化合物暴露对每种模型中肝毒性潜力的预测的影响。结果表明,与肝单体培养物相比,共培养模型具有更大的灵敏度。另外,通过将化合物的24小时TC 50 / C最大值除以在7或13天时测量的TC 50 / C max值将化合物的24小时tc 50 / c max值分开来确定“基于时间的比率”。结果表明这种方法可以作为传统肝毒性测量的有用辅助,提高早期筛查研究的预测值。强调 ?具有14天存活的体外肝细胞模型。还该模型使用大鼠,人和狗肝细胞/成纤维细胞共培养物。还将模型的敏感性和选择性与24h肝单一文献进行比较。还结果表明使用共培养模型的肝毒剂的敏感性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号